Shareable Research Card

CRNX - Crinetics Pharmaceuticals, Inc. Operating Lease, Liability, Current

This metric view shows CRNX - Crinetics Pharmaceuticals, Inc. operating lease, liability, current history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: Q4 2025
Latest reported value
$6,489,000

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Financial Metric Page

Crinetics Pharmaceuticals, Inc.: Operating Lease, Liability, Current

Latest period: Q4 2025. Period end: 31 Dec 2025. Units: USD. Frequency: quarterly.

Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.

What This Metric Tells You

  • Shows the reported level of operating lease, liability, current over 31 Mar 2019 - 31 Dec 2025.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 26 SEC fact rows for this metric and issuer.

How To Read This Chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use quarterly sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Operating Lease, Liability, Current levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

Rank Company Latest value Reported period Next step
1 AMAZON COM INC (["amzn"]) $12,655,000,000 Instant - 31 Dec 2025 Open AMAZON COM INC Operating Lease, Liability, Current
2 VERIZON COMMUNICATIONS INC (["vz"]) $4,542,000,000 Instant - 31 Dec 2025 Open VERIZON COMMUNICATIONS INC Operating Lease, Liability, Current
3 T-Mobile US, Inc. (["tmus", "tmusi", "tmusl", "tmusz"]) $3,814,000,000 Instant - 31 Dec 2025 Open T-Mobile US, Inc. Operating Lease, Liability, Current
4 AT&T INC. (["t", "tbb", "tpa", "tpc"]) $3,581,000,000 Instant - 31 Dec 2025 Open AT&T INC. Operating Lease, Liability, Current
5 Alphabet Inc. (["googl", "goog"]) $3,209,000,000 Instant - 31 Dec 2025 Open Alphabet Inc. Operating Lease, Liability, Current
6 ORACLE CORP (["orcl", "orclpd"]) $2,798,000,000 Instant - 28 Feb 2026 Open ORACLE CORP Operating Lease, Liability, Current

Metric Details

Metric
Operating Lease, Liability, Current (OperatingLeaseLiabilityCurrent)
Taxonomy
us-gaap
Units tracked
USD
Frequency coverage
quarterly
History range
31 Mar 2019 - 31 Dec 2025
Facts on this page
26
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Metric-level SEC endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Change (%)

Crinetics Pharmaceuticals, Inc. Quarterly Operating Lease, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $6,489,000 -$663,000 -9.3% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $6,441,000 -$972,000 -13% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $6,610,000 -$835,000 -11% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $6,883,000 +$1,091,000 +19% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $7,152,000 +$2,979,000 +71% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $7,413,000 +$3,424,000 +86% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $7,445,000 +$6,336,000 +571% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $5,792,000 +$4,713,000 +437% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $4,173,000 +$3,122,000 +297% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $3,989,000 +$2,967,000 +290% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $1,109,000 +$116,000 +12% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $1,079,000 +$114,000 +12% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $1,051,000 +$112,000 +12% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $1,022,000 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $993,000 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $965,000 +$105,000 +12% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $939,000 +$104,000 +12% 31 Dec 2021 10-Q 14 Nov 2022 2022 Q3
Q1 2021 $860,000 +$107,000 +14% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $835,000 +$111,000 +15% 31 Dec 2020 10-K 30 Mar 2021 2020 FY
Q3 2020 $810,000 +$114,000 +16% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $782,000 +$104,000 +15% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $753,000 +$88,000 +13% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $724,000 31 Dec 2019 10-K 09 Mar 2020 2019 FY
Q3 2019 $696,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $678,000 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 $665,000 31 Mar 2019 10-Q 13 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.